Elena Schiopu

An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial

Dinesh Khanna, Carlo Albera, Aryeh Fischer et al. · The Journal of Rheumatology · 2016 · 262 citations · Full text

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase <scp>II</scp> Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial

Dinesh Khanna, Cathie Spino, Sindhu R. Johnson et al. · Arthritis & Rheumatology · 2019 · 218 citations · Full text

Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis

Maureen D. Mayes, Lara Bossini‐Castillo, Olga Y. Gorlova et al. · The American Journal of Human Genetics · 2014 · 204 citations · Full text

Autoimmune Disease, Medicine, Immunology +6

Trial of Intravenous Immune Globulin in Dermatomyositis

Rohit Aggarwal, Christina Charles‐Schoeman, Joachim Schessl et al. · New England Journal of Medicine · 2022 · 181 citations · Full text

Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry

Robyn T. Domsic, Bharathi Lingala, Firas Alkassab et al. · Arthritis Care & Research · 2013 · 168 citations · Full text